Current Approaches to the Treatment and Management of Chronic Lymphocytic Leukaemia

@article{Montserrat1994CurrentAT,
  title={Current Approaches to the Treatment and Management of Chronic Lymphocytic Leukaemia},
  author={Prof. Emilio Montserrat and Ciril Rozman},
  journal={Drugs},
  year={1994},
  volume={47},
  pages={1-9}
}
Chronic lymphocytic leukaemia (CLL) patients in early clinical stage (Binet A; Rai 0) with nondiffuse bone marrow histopathology and low stable blood lymphocyte levels have long survival rates and should not be treated unless the disease progresses. In contrast, patients with poor prognostic features, such as advanced clinical stage (Binet B, C; Rai III, IV… CONTINUE READING